Inter Parfums (IPAR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for September 17, 2024, to vote on director elections, executive compensation, company name change, and auditor ratification.
Nine directors are nominated for re-election, with the board recommending a vote in favor.
Advisory votes include executive compensation approval and a proposal to change the company name to Interparfums, Inc.
Ratification of Forvis Mazars, LLP as independent auditor for fiscal 2024 is recommended.
Voting matters and shareholder proposals
Proposals include election of nine directors, advisory approval of executive compensation, company name change, and auditor ratification.
Board recommends voting in favor of all proposals.
Major shareholders, holding over 40% of shares, have indicated intent to vote in favor, making passage likely.
Shareholder proposals for the 2025 meeting must be submitted by May 20, 2025.
Board of directors and corporate governance
Board consists of nine directors, including a mix of executive and independent members.
Board diversity policy revised in 2024; currently compliant with Nasdaq Board Diversity Rule.
Board held 19 meetings in 2023, with all directors attending at least 75%.
Standing committees: Audit, Executive Compensation and Stock Option, and Nominating.
Code of Conduct and insider trading policies are in place and publicly available.
Latest events from Inter Parfums
- Record sales and EPS in FY2025, with strong brand growth and steady 2026 outlook.IPAR
Q4 202525 Feb 2026 - Record Q2 sales and margin gains support strong outlook and new launches for 2025.IPAR
Q2 20242 Feb 2026 - Record sales, robust innovation, and 4% growth outlook with higher dividend for 2025.IPAR
Q4 20242 Feb 2026 - Q1 2025 net sales up 5%, net income $42.5M, margins and guidance strong, key licenses renewed.IPAR
Q1 20252 Feb 2026 - Q3 2025 sales up 1%, net income up 6%, FY2025 sales seen at $1.47B, EPS $5.12.IPAR
Q3 202520 Jan 2026 - Record Q3 sales and net income up 17%, with 2024 guidance reaffirmed and strong holiday outlook.IPAR
Q3 202415 Jan 2026 - Annual meeting to vote on directors, executive pay, and share cancellation, with board support.IPAR
Proxy Filing1 Dec 2025 - Key votes include director elections, executive pay approval, and cancellation of 'hook shares.'IPAR
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, executive pay, name change, and auditor ratification.IPAR
Proxy Filing1 Dec 2025